959958-63-5Relevant academic research and scientific papers
Synthesis, molecular docking and antimicrobial evaluation of novel benzoxazole derivatives
Ertan-Bolelli, Tugba,Yildiz, Ilkay,Ozgen-Ozgacar, Selda
, p. 553 - 567 (2016/03/08)
In this research, previously and newly synthesized 5-amino-2-(4-substitutedphenyl/benzyl)benzoxazoles (3a-3l) and 2-substituted-5-(4-nitro/aminophenylsulfonamido)benzoxazoles (5a-5l, 6a-6l) were evaluated for their antimicrobial activities against Pseudom
Synthesis of some piperazinobenzoxazole derivatives and their antimicrobial properties
Arisoy, Mustafa,Temiz-Arpaci, Ozlem,Kaynak-Onurdag, Fatma,Ozgen, Selda
, p. 240 - 247 (2017/01/18)
A series of 2-(p-substitutedphenyl/benzyl)-5-[3-[4-[(p-chlorophenyl)/phenyl]piperazin-1-yl]propionamido]-benzoxazoles (3-22) have been synthesized towards discovering new antimicrobial compounds in order to fight against pathogens, which have become resistant to antibiotics and are the cause of increased mortality and morbidity throughout the world. Structures of new derivatives have been elucidated by spectral techniques. New and previously synthesized benzoxazoles have been evaluated for their antibacterial and antifungal activity against standard strains, and their drug-resistant isolates in comparison with reference drugs. This study is aimed to investigate the efficacy of the antimicrobial effect of different amido bridges on the same homologue structures of benzoxazole compounds. Compounds 3-22 exhibit broad antibacterial activity with MIC (Minimum Inhibitory Concentration) values of 128-256 μg/mL against Staphylococcus aureus and its isolate except for derivative 7 that has a MIC value of 32 μg/mL against S. aureus isolate and compounds 3 and 22 which have MIC value of 512 μg/mL against S. aureus. Also, the tested compounds 3-22 possess low antifungal activity with MIC values of 128 μg/mL against Candida albicans in comparison with antifungal reference drugs, fluconazole and amphotericin B.
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents
Ertan, Tugba,Yildiz, Ilkay,Tekiner-Gulbas, Betul,Bolelli, Kayhan,Temiz-Arpaci, Ozlem,Ozkan, Semiha,Kaynak, Fatma,Yalcin, Ismail,Aki, Esin
experimental part, p. 501 - 510 (2009/09/05)
A new series of 5(or 6)-nitro/amino-2-(substituted phenyl/benzyl)benzoxazole derivatives (1a-1m, 2a-2l) were synthesized and evaluated for antibacterial and antifungal activities against Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, Pse
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles
Alper-Hayta, Sabiha,Arisoy, Mustafa,Temiz-Arpaci, Oezlem,Yildiz, Ilkay,Aki, Esin,Oezkan, Semiha,Kaynak, Fatma
, p. 2568 - 2578 (2008/12/23)
The synthesis and antimicrobial activity of a new series of 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazole derivatives 3-12 were described. The in vitro antimicrobial activity of the compounds was determined against some Gram-positi
A study on the genotoxic activities of some new benzoxazoles
Oksuzoglu, Emine,Temiz-Arpaci, Ozlem,Tekiner-Gulbas, Betul,Eroglu, Hatice,Sen, Gulseren,Alper, Sabiha,Yildiz, Ilkay,Diril, Nuran,Aki-Sener, Esin,Yalcin, Ismail
, p. 1 - 14 (2008/04/01)
The Bacillus subtilis rec assay has been specially developed to detect DNA-damaging potential in chemicals, with the rationale based on the relative difference of survival of a DNA repair combination proficient strains and its deficient strain, which is i
